GE HealthCare Technologies Inc
Company Profile
Business description
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Contact
500 West Monroe Street
ChicagoIL60661
USAT: +1 833 735-1139
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
54,000
Stocks News & Analysis
stocks
ASX utility share downgraded as electricity prices fall
stocks
Chart of the Week: AI market leader is now surprisingly cheap
stocks
Weekly earnings wrap: Rio Tinto leads the way
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,452.00 | 42.10 | 0.45% |
| CAC 40 | 8,728.42 | 59.13 | 0.68% |
| DAX 40 | 26,205.40 | 79.10 | 0.30% |
| Dow JONES (US) | 54,164.51 | 184.61 | -0.34% |
| FTSE 100 | 10,883.06 | 5.24 | -0.05% |
| HKSE | 25,530.28 | 385.54 | -1.49% |
| NASDAQ | 26,424.61 | 61.17 | 0.23% |
| Nikkei 225 | 65,683.26 | 617.18 | -0.93% |
| NZX 50 Index | 13,958.06 | 39.12 | -0.28% |
| S&P 500 | 7,727.52 | 3.97 | 0.05% |
| S&P/ASX 200 | 9,271.60 | 41.80 | 0.45% |
| SSE Composite Index | 3,900.35 | 21.92 | 0.57% |